Five-year real-world drug survival of dupilumab in severe atopic dermatitis and associate predictors
Background Atopic dermatitis (AD) profoundly impacts patients’ lives, necessitating long-term systemic treatments.Methods This retrospective study involved 709 severe AD patients receiving dupilumab. Drug survival (DS) was analyzed using Kaplan-Meier curves, evaluating reasons for discontinuation. T...
Na minha lista:
| Principais autores: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis Group
2024-12-01
|
| Serier: | Journal of Dermatological Treatment |
| Fag: | |
| Online adgang: | https://www.tandfonline.com/doi/10.1080/09546634.2024.2404718 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
